Symptomatic therapy for underrecognized manifestations of multiple sclerosis
- 23 April 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 58 (8_suppl_4) , S32-S39
- https://doi.org/10.1212/wnl.58.8_suppl_4.s32
Abstract
The symptoms that affect individuals with MS are diverse and change over time. Addressing symptoms in a multidisciplinary fashion and helping patients address problems as they occur are the major elements of symptom management. Successful management involves treating not only the more readily recognized manifestations of MS but also the less apparent MS features, including fatigue, cognitive loss, mood disturbance, and pain. Management of these symptoms is reviewed.Keywords
This publication has 62 references indexed in Scilit:
- Neuropsychological effects of interferon ?-1a in relapsing multiple sclerosisAnnals of Neurology, 2000
- Fatigue in multiple sclerosis and its relationship to depression and neurologic disabilityMultiple Sclerosis Journal, 2000
- Gamma Knife Treatment of Trigeminal Neuralgia: Clinical and Electrophysiological StudyStereotactic and Functional Neurosurgery, 1998
- A comprehensive assessment of the cost of multiple sclerosis in the United StatesMultiple Sclerosis Journal, 1998
- Guidelines for the therapeutic use of botulinum toxin in movement disordersThe Italian Journal of Neurological Sciences, 1997
- Executive function in multiple sclerosis. The role of frontal lobe pathologyBrain, 1997
- The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosisJournal of Clinical Psychology, 1992
- Cognitive dysfunction in multiple sclerosis.Neurology, 1991
- Treatment of Pathologic Laughing and Weeping with AmitriptylineNew England Journal of Medicine, 1985
- An Evaluation of Cognitive-Behaviour Therapy for Depression in Patients with Multiple SclerosisThe British Journal of Psychiatry, 1984